Zdrowie i gospodarka · 29/09/2006
FDA Withdraws Three Electronic Submission Guidances
The FDA is withdrawing three guidances related to electronic submissions for New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs), citing inconsistencies with more recent guidance and outdated submission formats.
Source: Federal Register — Food and Drug AdministrationOpen original release →